171 related articles for article (PubMed ID: 8587166)
21. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.
Pal RB; Pal P; Jain S; Kulkarni KP
J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519
[TBL] [Abstract][Full Text] [Related]
22. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
Cooper CE; Slocombe B; White AR
J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
[TBL] [Abstract][Full Text] [Related]
23. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G
Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
[TBL] [Abstract][Full Text] [Related]
24. [Clinical study of BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
Nagamatsu I; Horiguchi S; Hatae T
Jpn J Antibiot; 1985 Feb; 38(2):287-95. PubMed ID: 3847518
[TBL] [Abstract][Full Text] [Related]
25. [beta-lactamase-producing activity and antimicrobial susceptibility of major pathogenic bacteria isolated from clinical samples. Japan beta-lactamase Research Group].
Oguri T; Igari J; Hiramatsu K; Watanabe A; Inoue M; Abe M; Yamane N; Aihara M; Hashimoto H;
Jpn J Antibiot; 2002 Sep; 55 Suppl A():1-28. PubMed ID: 12599526
[TBL] [Abstract][Full Text] [Related]
26. Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
Bedenić B; Zagar Z
J Chemother; 1994 Dec; 6(6):383-7. PubMed ID: 7699424
[TBL] [Abstract][Full Text] [Related]
27. [Antimicrobial activities of cefcapene against clinical isolates from respiratory tract infections of outpatients].
Ishihara R; Ishii Y; Suzuki Y; Nakazawa A; Deguchi K; Toyonaga Y
Jpn J Antibiot; 1998 Jan; 51(1):1-10. PubMed ID: 9557272
[TBL] [Abstract][Full Text] [Related]
28. [Bactericidal effect of cefadroxil, amoxicillin alone or in combination with clavulanic acid in sera of healthy volunteers].
Etesse-Carsenti H; Garraffo R; Bernard E; de Salvador F; Pradier C; Durant J; Mondain V; Drugeon HB; Dellamonica P
Pathol Biol (Paris); 1991 Dec; 39(10):972-7. PubMed ID: 1805138
[TBL] [Abstract][Full Text] [Related]
29. [In vitro susceptibilities of causative organisms isolated from patients with primary respiratory tract infections to BRL 25000 (clavulanic acid/amoxicillin)].
Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Oda S; Matsumoto Y; Ikegami R; Sato K; Fukumoto T
Jpn J Antibiot; 1985 Oct; 38(10):2797-808. PubMed ID: 3878415
[TBL] [Abstract][Full Text] [Related]
30. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Sato Y; Iwata S; Akita H; Murai T; Ibara M; Oikawa T; Osano M
Jpn J Antibiot; 1985 Feb; 38(2):327-41. PubMed ID: 3847521
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
[TBL] [Abstract][Full Text] [Related]
32. Antibacterial activity and kill kinetics of amoxicillin-clavulanic acid combinations against Escherichia coli and Klebsiella aerogenes.
Fuglesang JE; Bergan T
Infection; 1983; 11(6):329-35. PubMed ID: 6365790
[TBL] [Abstract][Full Text] [Related]
33. Development of beta-lactamase inhibitors.
Sutherland R
J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
[TBL] [Abstract][Full Text] [Related]
34. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
[TBL] [Abstract][Full Text] [Related]
35. [In vitro activity of cefuroxime against Moraxella (Branhamella) catarrhalis].
Laurans G; Gaudio F; Ducroix JP; Orfila J
Pathol Biol (Paris); 1991 May; 39(5):391-5. PubMed ID: 1909016
[TBL] [Abstract][Full Text] [Related]
36. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
[TBL] [Abstract][Full Text] [Related]
37. Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
Cuffini AM; De Renzi G; Tullio V; Paizis G; Carlone NA
Drugs Exp Clin Res; 1996; 22(1):9-15. PubMed ID: 8839632
[TBL] [Abstract][Full Text] [Related]
38. In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin.
Wise R; Andrews JM; Bedford KA
Antimicrob Agents Chemother; 1978 Mar; 13(3):389-93. PubMed ID: 122520
[TBL] [Abstract][Full Text] [Related]
39. Bacteriological investigations with beta-lactamase inhibitors.
Ullmann U
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):222-9. PubMed ID: 6289565
[TBL] [Abstract][Full Text] [Related]
40. [Antibacterial activity of oral Cephems against various clinically isolated strains].
Oshiro T; Fukutomi Y; Takayanagi M; Kusaba K; Nagasawa Z; Aoki Y; Nagayama A
Jpn J Antibiot; 2003 Dec; 56(6):681-90. PubMed ID: 15007876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
